Bronchopulmonary dysplasia

American Journal of Respiratory and Critical Care Medicine

Volumn 163, Issue 7, 2001, Pages 1723-1729

  Jobe, A H ^a   Bancalari, E ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOMBESIN; INTERLEUKIN 11; INTERLEUKIN 6; INTERLEUKIN 8; LUNG SURFACTANT; MACROPHAGE INFLAMMATORY PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTIFICIAL VENTILATION; CONFERENCE PAPER; DISEASE SEVERITY; FORCED EXPIRATORY FLOW; HUMAN; INFANT NUTRITION; LUNG DEVELOPMENT; LUNG DYSPLASIA; LUNG INJURY; NONHUMAN; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PRIORITY JOURNAL;

EID: 0034961202     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.163.7.2011060     Document Type: Conference Paper

References (66)

1. Pulmonary disease following respirator therapy of hyaline-membrane disease: Bronchopulmonary dysplasia
2. Report of Workshop on Bronchopulmonary Dysplasia
3. Bronchopulmonary dysplasia: Unresolved neonatal acute lung injury
4. Decreased alveolarization in baboon survivors with bronchopulmonary dysplasia
5. Neonatal chronic lung disease in extremely immature baboons
6. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1993 through December 1994
7. The new BPD: An arrest of lung development
8. Clinical course and lung function abnormalities during development of neonatal chronic lung disease
9. Atypical chronic lung disease patterns in neonates
10. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops
11. Structural aspects of prenatal and postnatal development and growth of the lung
12. Postnatal lung development and its impairment by glucocorticoids
13. Influence of postnatally administered glucocorticoids on rat lung growth
14. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia
15. Lung elastic tissue maturation and perturbations during the evolution of chronic lung disease
16. Chronic lung injury in preterm lambs
17. High-frequency oscillatory ventilation: Effects on lung function, mechanics, and airway cytokines in the immature baboon model for neonatal chronic lung disease
18. Subendothelial cells from normal bovine arteries exhibit autonomous growth constitutively activated intracellular signaling
19. Chronic hypoxia induces exaggerated growth responses in pulmonary artery adventitial fibroblasts: Potential contribution of specific protein kinase c isozymes
20. Association between the surfactant protein A (SP-A) gene locus and respiratory-distress syndrome in the Finnish population
21. Molecular mechanisms controlling lung morphogenesis
22. Defects in tracheoesophageal and lung morphogenesis in Nkx2.1(-/-) mouse embryos
23. Bioactive transforming growth factor-beta in the lungs of extremely low birthweight neonates predicts the need for home oxygen supplementation
24. Functional and pathological effects of prolonged hyperoxia in neonatal mice
25. Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized, controlled trial: I. primary outcomes
26. Effects of different styles of ventilation on cytokine expression in preterm lamb lung
27. Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease?
28. Role of neutrophils in lung vascular injury and edema after premature birth in lambs
29. Circulating neutrophil concentration and respiratory distress in premature infants
30. Alpha1-proteinase inhibitor therapy for the prevention of chronic lung disease of prematurity: A randomized, controlled trial
31. Inflammatory mediators and bronchopulmonary dysplasia
32. Role of ureaplasma urealyticum in lung disease of prematurity
33. Bombesin-like peptide mediates lung injury in a baboon model of bronchopulmonary dysplasia
34. Formation of pulmonary alveoli and gas-exchange surface area: Quantitation and regulation
35. Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in rats
36. Retinoic acid receptor-beta: An endogenous inhibitor of the perinatal formation of pulmonary
37. Retinoic acid treatment partially rescues failed septation in rats and in mice
38. Intralipid increases lung polyunsaturated fatty acids and protects newborn rats from oxygen toxicity
39. Effect of early initiation of intravenous lipid administration on the incidence and severity of chronic lung disease in premature infants
40. Vitamin A supplementation for extremely-low-birth-weight infants: National Institute of Child Health and Human Development Neonatal Research Network
41. Inositol supplementation in premature infants with respiratory distress syndrome
42. Prophylactic effects of recombinant human superoxide dismutase in neonatal lung injury
43. Improved pulmonary outcome at one year corrected age in premature neonates treated with recombinant human superoxide dismutase
44. Long-term follow-up of premature infants treated with prophylactic, intratracheal recombinant human CuZn superoxide dismutase
45. Scientific rationale for the use of antenatal glucocorticoids to promote fetal development
46. Glucocorticoid regulation of surfactant components in immature lambs
47. TGF-beta1 inhibits surfactant component expression and epithelial cell maturation in cultured human fetal lung
48. Postnatal steroids: Short term gain, long term pain?
49. Evidence of early adrenal insufficiency in babies who develop bronchopulmonary dysplasia
50. Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants
51. Pulmonary hypertension in chronic lung disease in infancy: Pathogenesis, pathophysiology and treatment
52. Inhibition of angiogenesis decreases alveolarization in the developing rat lung
53. Randomized controlled trial of inhaled nitric oxide in premature neonates with severe hypoxemic respiratory failure
54. Ventilator-induced lung injury: Mechanisms and clinical correlates
55. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome
56. Randomized trial of permissive hypercapnia in preterm infants
57. Intrauterine infection and preterm delivery
58. Amniotic fluid interleukin-6: Correlation with upper genital tract microbial colonization and gestational age in women delivered after spontaneous labor versus indicated delivery
59. Evaluation of criteria for chronic lung disease in surviving very low birth weight infants
60. Functional assessment of a multicenter very low-birth-weight cohort at age 5 years: Newborn Lung Project
61. Expiratory flow limitation in infants with bronchopulmonary dysplasia
62. Serial determination of pulmonary function in infants with chronic lung disease
63. Pulmonary function until two years of life in infants with bronchopulmonary dysplasia
64. Late pulmonary sequelae of bronchopulmonary dysplasia
65. Abnormal pulmonary outcomes in premature infants: Prediction from oxygen requirement in the neonatal period